To understand why αTOS acts as a pure agonist in prostate carcinoma but behaves as an antagonist in melanoma, we assessed Reactive Oxygen Species (ROS) and nuclear translocation of the Apoptosis Inducing Factor (AIF). The gene discussed is AIFM1; the disease is prostate carcinoma.